|
The Immunohistochemistry Antibody Company
|
- Home
-
Products
- All Antibodies
- IHC-plus Antibodies
-
Services
- Immunohistochemistry Studies
- Tissue Cross-Reactivity Screening
- Distributors
-
Resources
- About our Tissue Bank
- Customer Support
- How to Buy
- IHC-plus Protocol
- LSBio Media
- Publications
- Antibody Reports
-
Company
- About LifeSpan
- Press Releases
- Holiday Schedule
- Contact Us
|
|
| Catalog ID: |
LS-SLYCA17 |
| Product Name: |
Lymphoma Screen 17 |
| Description: |
Lymphoma, multiple myeloma, and lymph node |
| Format: |
FFPE |
| Category: |
Human Tumor |
| QA/QC: |
H&E reviewed |
| Storage: |
Short term RT; Long term 4ºC |
| Clinical History: |
No |
| Tissue Marker: |
No |
| Stage/Grade: |
No |
| Core Diameter: |
1.5 mm |
| Core Thickness: |
5 µm |
| Cases: |
40 |
| Cores: |
40 |
| Slides Per Set: |
1 |
LS-SLYCA17 Tissue Microarray Map
Slide Number 1
| LABEL | | | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | | A | Lym | Lym | Lym | Lym | Lym | Lym | Lym | Lym | Lym | Lym | | B | Lym | Lym | Lym | Lym | Lym | Lym | Lym | Lym | Lym | Lym | | C | Lym | Lym | Lym | Lym | Lym | Lym | Lym | Lym | Lym | Lym | | D | Bon | Bon | Bon | Bon | Bon | Lym | Lym | Lym | Lym | Lym |
|
Diagnosis Type Legend| Benign non-neoplastic | Diseased | Inflammatory | Malignant | Metastatic | Tumor | Unknown |
Element Tissue LegendBone (Bon); Lymph node (Lym);
LS-SLYCA17 Element Details
| Slide | Position | Species | Gender | Age | Tissue | Diagnosis | Diagnosis Type |
|---|
| 1 | A1 | Human | M | 31 y | Lymph node (Lym) | Lymphoma, Large B-cell | Malignant |
| 1 | A2 | Human | F | 40 y | Lymph node (Lym) | B-cell lymphoma | Malignant |
| 1 | A3 | Human | F | 62 y | Lymph node (Lym) | B-cell lymphoma | Malignant |
| 1 | A4 | Human | M | 45 y | Lymph node (Lym) | B-cell lymphoma | Malignant |
| 1 | A5 | Human | F | 40 y | Lymph node (Lym) | Lymphoma, Large B-cell | Malignant |
| 1 | A6 | Human | M | 67 y | Lymph node (Lym) | B-cell lymphoma | Malignant |
| 1 | A7 | Human | M | 50 y | Lymph node (Lym) | B-cell lymphoma | Malignant |
| 1 | A8 | Human | F | 76 y | Lymph node (Lym) | B-cell lymphoma | Malignant |
| 1 | A9 | Human | M | 76 y | Lymph node (Lym) | Lymphoma, Large B-cell | Malignant |
| 1 | A10 | Human | M | 40 y | Lymph node (Lym) | B-cell lymphoma | Malignant |
| 1 | B1 | Human | M | 64 y | Lymph node (Lym) | T cell lymphoma | Malignant |
| 1 | B2 | Human | M | 8 y | Lymph node (Lym) | T cell lymphoma | Malignant |
| 1 | B3 | Human | M | 55 y | Lymph node (Lym) | T cell lymphoma | Malignant |
| 1 | B4 | Human | F | 46 y | Lymph node (Lym) | T cell lymphoma | Malignant |
| 1 | B5 | Human | F | 60 y | Lymph node (Lym) | T cell lymphoma | Malignant |
| 1 | B6 | Human | M | 38 y | Lymph node (Lym) | T cell lymphoma | Malignant |
| 1 | B7 | Human | M | 36 y | Lymph node (Lym) | T cell lymphoma | Malignant |
| 1 | B8 | Human | M | 59 y | Lymph node (Lym) | T cell lymphoma | Malignant |
| 1 | B9 | Human | F | 40 y | Lymph node (Lym) | T cell lymphoma | Malignant |
| 1 | B10 | Human | M | 45 y | Lymph node (Lym) | T cell lymphoma | Malignant |
| 1 | C1 | Human | M | 18 y | Lymph node (Lym) | Hodgkin's lymphoma | Malignant |
| 1 | C2 | Human | M | 41 y | Lymph node (Lym) | Hodgkin's lymphoma | Malignant |
| 1 | C3 | Human | M | 35 y | Lymph node (Lym) | Hodgkin's lymphoma | Malignant |
| 1 | C4 | Human | F | 48 y | Lymph node (Lym) | Hodgkin's lymphoma | Malignant |
| 1 | C5 | Human | M | 68 y | Lymph node (Lym) | Hodgkin's lymphoma | Malignant |
| 1 | C6 | Human | M | 37 y | Lymph node (Lym) | Hodgkin's lymphoma | Malignant |
| 1 | C7 | Human | M | 27 y | Lymph node (Lym) | Hodgkin's lymphoma | Malignant |
| 1 | C8 | Human | M | 3 y | Lymph node (Lym) | Hodgkin's lymphoma | Malignant |
| 1 | C9 | Human | F | 37 y | Lymph node (Lym) | Hodgkin's lymphoma | Malignant |
| 1 | C10 | Human | M | 30 y | Lymph node (Lym) | Hodgkin's lymphoma | Malignant |
| 1 | D1 | Human | M | 62 y | Bone (Bon) | Myeloma | Malignant |
| 1 | D2 | Human | F | 46 y | Bone (Bon) | Myeloma | Malignant |
| 1 | D3 | Human | F | 43 y | Bone (Bon) | Myeloma | Malignant |
| 1 | D4 | Human | M | 64 y | Bone (Bon) | Myeloma | Malignant |
| 1 | D5 | Human | M | 58 y | Bone (Bon) | Myeloma | Malignant |
| 1 | D6 | Human | M | 40 y | Lymph node (Lym) | Normal | Benign non-neoplastic |
| 1 | D7 | Human | M | 16 y | Lymph node (Lym) | Normal | Benign non-neoplastic |
| 1 | D8 | Human | M | 45 y | Lymph node (Lym) | Normal | Benign non-neoplastic |
| 1 | D9 | Human | F | 15 y | Lymph node (Lym) | Normal | Benign non-neoplastic |
| 1 | D10 | Human | F | 18 y | Lymph node (Lym) | Normal | Benign non-neoplastic |
Copyright © 2013 LifeSpan BioSciences, Inc. All Rights Reserved
